newsfilter
← Latest News
GlobeNewswire·

Acer Therapeutics Receives Notice of Allowance of Key US Patent Application Covering EDSIVO™ (celiprolol)

NEWTON, Mass., Oct. 26, 2022 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (NASDAQ:ACER), a clinical stage pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious rare